Toll-Like Receptor 2 (tlr2) and Tlr9 Play Opposing Roles in Host Innate Immunity Against Salmonella Enterica Serovar Typhimurium Infection

Renhui Zhan,Qiuju Han,Cai Zhang,Zhigang Tian,Jian Zhang

DOI: https://doi.org/10.1128/iai.02870-14

2015-01-01

Infection and Immunity

Abstract:ABSTRACTToll-like receptors (TLRs) are evolutionarily conserved host proteins that are essential for effective host defense against pathogens. However, recent studies suggest that some TLRs can negatively regulate immune responses. We observed here that TLR2 and TLR9 played opposite roles in regulating innate immunity against oral infection ofSalmonella entericaserovar Typhimurium in mice. WhileTLR9−/−mice exhibited shortened survival, an increased cytokine storm, and more severeSalmonellahepatitis than wild-type (WT) mice,TLR2−/−mice exhibited the opposite phenomenon. Further studies demonstrated that TLR2 deficiency and TLR9 deficiency in macrophages both disrupted NK cell cytotoxicity againstS. Typhimurium-infected macrophages by downregulating NK cell degranulation and gamma interferon (IFN-γ) production through decreased macrophage expression of the RAE-1 NKG2D ligand. But more importantly, we found thatS. Typhimurium-infectedTLR2−/−macrophages upregulated inducible nitric oxide synthase (iNOS) expression, resulting in a lower bacterial load than that in WT macrophagesin vitroand liversin vivoas well as low proinflammatory cytokine levels. In contrast,TLR9−/−macrophages showed decreased reactive oxygen species (ROS) expression concomitant with a high bacterial load in the macrophages and in livers ofTLR9−/−mice.TLR9−/−macrophages were also more susceptible than WT macrophages toS. Typhimurium-induced necroptosisin vitro, likely contributing to bacterial spread and transmissionin vivo. Collectively, these findings indicate that TLR2 negatively regulates anti-S. Typhimurium immunity, whereas TLR9 is vital to host defense and survival againstS. Typhimurium invasion. TLR2 antagonists or TLR9 agonists may thus serve as potential anti-S. Typhimurium therapeutic agents.